Process Analytical Technology Market Insights To Witness Notable Growth During the Forecast Period 2023-2032

 

Market summery

The Process Analytical Technology Market Size is projected to reach at 13.1% CAGR during the forecast period 2023-2032. The FDA defines process analytical technology (PAT) as a mechanism for designing, studying, and controlling pharmaceutical manufacturing processes by measuring essential process parameters that affect critical quality attributes of an active pharmaceutical component (API). The primary goal of process analytical technology is to reduce production cycling time, batch rejection and maximize automation. According to a report published by MRFR, the market is estimated to accomplish a formidable CAGR in the duration of the forecast period.

Process Analytical Technology Industry have played an essential role in the pharmaceutical industry's process development and scale-up of asymmetric syntheses of chiral compounds, including active medicinal ingredients. The necessity for automation and quality control in pharmaceutical manufacturing and escalating regulatory restrictions for drug manufacture and pharmaceutical production are powerful factors for the use of the process analytics sensors.

Competitive Analysis

Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Government assistance is expected to support worldwide market development in the next years. Market developments and research are expected to generate attractive growth opportunities in the next years. The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth.

The Process Analytical Technology Market Players are

·          PerkinElmer, Inc. (U.S.),

·          Thermo Fisher Scientific, Inc. (U.S.),

·          Agilent Technologies, Inc. (U.S.),

·          Bruker Corporation (U.S.), and

·          Danaher Corporation (U.S.).

Segmental Analysis

The segmentation of the Process Analytical Technology Market Insights is conducted on the basis of product, region, and application.

Based on application, the process analytical technology market consists of spectroscopy which is further segmented into molecular, mass, and atomic spectroscopy, chromatography which is further segmented into liquid and gas; electrophoresis, and particle size analysis.

The process analytical technology market consists of a sensor, probes, and analyzers based on product. Based on regions, the process analytical technology market consists of North America, Europe, Asia-Pacific, and other global markets.

Detailed Regional Analysis 

The regional assessment of the Process Analytical Technology Market Outlook consists of North America, Europe, Asia-Pacific, and other global markets. During the projected period, North America is estimated to account for the greatest share of the market. The presence of a large number of market participants and regulatory compliance pushing the use of PAT are fueling the growth of the North American market. However, the Asia-Pacific region is expected to increase the most during the forecast period. The Asia-Pacific market for process analytical technology has increased dramatically in recent years, owing to increased government funding in the biotech industry, an increase in the number of contract research and manufacturing institutions, and an increased focus of international players on emerging markets.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Nuclear Imaging Devices Market Share accelerating a CAGR during the forecast period 2023-2032

 

Market Highlights

The global Nuclear Imaging Devices Market Share is expected to grow significantly over the forecast period. It is anticipated that the market is projected to register a CAGR of 5.1% over the forecast period 2023-2032.

The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.

Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.

However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.

Key Players

the global nuclear imaging devices market players are

           ·          Philips Healthcare,

           ·          Digirad Corporation,

           ·          Neusoft Medical Systems Co., Ltd.,

           ·          Progenics Pharmaceuticals Inc.,

           ·          Cannon Inc.,

           ·          Surgiceye GmbH,

           ·          CMR Naviscan,

           ·          Mediso Medical Imaging Systems Ltd.,

           ·          Agfa-Gevaert Group,

           ·          General Electric Company,

           ·          DDD-Diagnostic A/S,

           ·          Spectrum Dynamics Medical,

           ·          FMI Medical Systems, Inc.,

           ·          Segamicorp, and others.

Segmentation

The global nuclear imaging devices market is segmented based on technology, application, end user, and region.

·         The global nuclear imaging devices market outlook, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.

·         Based on application, the market is segmented into oncology, cardiology, neurology, and others.

·         Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.

·         The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Regional Analysis

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The nuclear imaging devices market insights in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Healthcare Information Systems Market Outlook, Trends, Size, Share, Players, Scope, Regional Demand and Forecast To 2032

 

Market Synopsis:

The healthcare information systems market share increase in adoption of the latest technologies in the healthcare sector is supposed to drive the growth of the healthcare information systems market in the foreseeable future. A report offered by Market Research Future (MRFR) indicates that the market is prognosticated to mark 12.90% CAGR over the forecast period 2023 to 2032. The developments in the healthcare IT industry is projected to drive the expansion of the healthcare information systems market in the upcoming years.

The healthcare system is growing at a rapid pace which has led to the generation of vast amount of data everyday. The efficient management of these data is one of the top-most priorities of healthcare organizations. Thus, the healthcare information software market is presumed to gain traction in the nearby future. In addition, rising number of patients on the global front, coupled with expansion of healthcare service providers, is expected to drive the augmentation of the healthcare information system market in the upcoming years.

The healthcare industry is expanding, which is supposed to motivate adoption of advanced technologies in the industry. This ongoing trend of technological development is supposed to drive the growth of the healthcare information systems market in the years to come. In addition, the introduction of the blockchain technology is set to revolutionize the healthcare information systems market in the coming years.

Competitive Dashboard:

The healthcare systems market players of the assessed in the report are Agfa-Gevaert N.V., Allscripts Healthcare Solutions Inc., Athenahealth Inc., Carestream Health, GE Healthcare, Cerner Corporation, Philips Healthcare, McKesson Corporation, NextGen Healthcare, Medidata Solutions Inc., and Siemens Healthineers.

Market Segmentation:

The type-based segments of the healthcare information systems market outlook are hospital information systems, laboratory information systems, pharmacy information systems, medical imaging information system, and revenue cycle management. The sub-segments of the hospital information systems segment are population health management, electronic health record, real-time healthcare, electronic medical record, patient engagement solutions, and others. The sub-segments of the pharmacy information systems segment are prescription management, inventory management, automated dispensing systems, and others. The sub-segmentation of the medical imaging information system covers monitoring analysis software, picture archiving & communication systems, radiology information systems, and others.

On the basis of component, the segments of the healthcare information systems market are software and hardware.

The deployment-based segments of the healthcare information systems market are on premise, web-based, and cloud-based.

The end-user segments of the healthcare information systems market identified are academic and research institution, hospitals, diagnostics center, and others.

Regional Analysis:

This report presents a detailed geographical analysis of the healthcare information systems market based on regions and further segmented into countries. The regional segments profiled for the study are – Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Americas held the forefront position and is supposed to retain it. Increasing demand for quality diagnostics is one of the primary drivers of the healthcare information systems market in the region. In addition, the support extended by the governments is also supposed to drive market growth.

Asia Pacific is expected to observe a high rate of growth. It is due to the developments in the healthcare IT industry. Also, the rising demand for technological innovations in the industry is prognosticated to drive the growth of the healthcare information systems market in APAC. The MEA is supposed to hold the least share. However, the region resonates strong growth potential.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Single-Photon Emission Computed Tomography Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2032

 

Market Highlights

 

Single-Photon Emission Computed Tomography Market Share is expected to reach at 6.90% CAGR during the forecast period 2023-2032.

The growing acceptance of Single-Photon Emission Computed Tomography (SPECT) accustomed by its technical advances is one of the major trends witnessed in the global SPECT market over the forecast period. Imaging devices are becoming more advanced, efficient, and evolved in terms of technology. The SPECT scanner has two integral parts namely computed tomography (CT) and a radioactive material (tracer). Basically, these tracers are used to diagnose and predict outcomes in various disease states by monitoring the therapeutic effects.

 

The Single-Photon Emission Computed Tomography market insights is expected to witness tremendous growth owing to the new 99mtc labelled agents for visualizing biologically significant events, and integration of X-ray tomography (CT) In SPECT. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for skilled professionals, and reimbursement issues, is likely to curb the market growth during the forecast period.

 

Key players

 

The global market is manifested with the presence of limited companies, leading to the consolidated nature of the market. The industry rivalry are expected to remain high throughout the forecast period. Several small and larger companies are involved in development of Single-Photon Emission Computed Tomography (SPECT) for diagnostic applications.

 

The Single-Photon Emission Computed Tomography Market Players are GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.

PNPMedM, NuCare Inc., and others.

Segmentation

 

The global Single-Photon Emission Computed Tomography market outlook is segmented into type, application, end-users. The Single-Photon Emission Computed Tomography (SPECT) market, by type, the market is segmented into hybrid SPECT systems, and standalone SPECT systems. On the basis of application, the Single-Photon Emission Computed Tomography (SPECT) market is bifurcated into oncology, cardiology, neurology, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic imaging centers, academic & research centers, and others.

 

Regional Analysis

 

The Americas is the largest in the market owing to the improving research infrastructure in the region, coupled with the rising awareness among patients and physicians for radioisotopes. Further, SPECT has reportedly been combined with CT and MRI to provide detailed anatomical and metabolic information. It is currently exhibiting a highly lucrative growth rate due to an increased use of SPECT for diagnosis of cardiac diseases, brain diseases, etc.

 

The European region is the second largest SPECT market over the forecast period due to high acceptance of SPECT in research & development along with the rising incidence of chronic disease like cancers are also accountable for the growth of the Single-Photon Emission Computed Tomography (SPECT) market. 

The Asia Pacific region is likely to develop at the uppermost CAGR for the Single-Photon Emission Computed Tomography (SPECT) market in the years to come. Moreover, the rising diagnostic care services both at the hospitals and at community level are expected to influence the market in a positive way. The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Irritable Bowel Syndrome Treatment Market Outlook, Trends, Size, Share, Players, Scope, Regional Demand and Forecast To 2032

 

Overview:

 

The Global Irritable Bowel Syndrome Treatment Market Share is showing impressive signs of attaining a CAGR of 8.1% between 2023 and 2032. Irritable bowel syndrome is a disease that triggers immense pain in the stomach that, if not cured in time, could lead to depression. The problem can be a long-lasting one. Market Research Future (MRFR) report has found out that the market is evolving due to the growing awareness that is making people seek better treatment.

Several factors like better market awareness, high expenditure capacity, and increasing ingress of various technologies can impact the global market. Pharmaceutical industries are impacting the market with various innovation and others.

Competitive Landscape:

Global Irritable Bowel Syndrome Treatment Market Players are Allergan Inc., Valeant Pharmaceuticals international, Inc., Lexicon Pharmaceuticals, Inc., Astellas Pharma, Inc., Mallinckrodt, Synergy Pharmaceuticals Inc., Nestle Health Science, Ardelyx, Inc., Ironwood Pharmaceuticals, and Abbott. MRFR recorded the latest moves initiated by these companies to make sure that a chart can be drawn for the market in the future, which can be used to predict various movements in the coming days.

Segmentation:

The report on the global irritable bowel syndrome treatment market outlook makes it extensive by segmenting the market into type, drug type, and end user. These segments carry various factorial details and trigger better understanding with volume-wise and value-wise understanding.

By type, the global market for irritable bowel syndrome treatment includes IBS-C, IBS-D, and IBS-M. IBS-D is has the potential to emerge as the major shareholder over the forecast period.

By drug type, the report on the global irritable bowel syndrome treatment market insights includes linaclotide, lubiprostone, rifaximin, eluxadoline, and alosetron. The Linaclotide segment has the potential to take over the market.

By end use, the report containing study of the global irritable bowel syndrome treatment market encompasses clinics, research laboratories, hospitals, and others. The Hospitals segment has the better market coverage.

Regional Analysis:

North America is expected to make better contribution for the irritable bowel syndrome market. The regional market has better market opportunities due to their high expenditure capacity. Better healthcare facilities, high investment for research & development sector, medicines lined up in the pipeline, and others are expected to make strong contributions for the regional market. In addition, the presence of top-notch pharmacies and countries like the US, Canada, and others are expected to earn more revenues for the market.

Europe is expected to portray similar growth patterns, which can trigger a high influx of revenues. The market is also known for the presence of several market players who are impacting it with their innovations. On the other hand, they are collaborating with various other players to make substantial impact on the market.

The APAC market has better opportunities as the global players are looking for constant incorporation of efforts from regional governments, which they are receiving. In addition, the region has become a perfect business expansion plans for these companies. Hike in expenditure capacity, better medical facilities, and others are expected to make the market contribute the most in the coming years. Its massive population can also play a crucial role by allowing easy permeation for the market.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

North America Dental Consumables Market Share Expected to reach a notable valuation by 2032

 

Dental Consumables Market – Overview

The focus towards dental health has increased the demand for dental consumables significantly over the forecast period. Market focused reports related to the healthcare domain among others recently have been made available by Market Research Future which publishes reports on this market. The North America Dental Consumables Market Share is expected to grow at a CAGR of 2.7% in the forecast period 2023-2032

Increased number of dental practitioners who are utilizing dental consumables has risen considerably in the past few years. Advances in dental procedures have positively reinforced the growth trends of the dental consumables market. Increasing numbers of dental professionals around the world are expected to be instrumental in the development of the market in the coming years. Innovations related to the various areas of dentistry are significant in the expansion of the market. Dental consumables are extensively used due to an escalation in demand for minimally invasive cosmetic dental procedures, particularly in aesthetic dentistry.

Competitive Analysis

The accelerating levels of diversification in the industry, have permitted the companies to use many opportunities available in the industry. The companies in this market are acclimatizing to the state of events by employing portfolio upgrades and preserving financial liquidity. The market value has been enhanced by the constant delivery of customer value. The market competitors are creating their blueprints for corporate strategy in a way that can bring about the best results for development in the current scenario, while also alongside enhancing their product’s value. The prospect for development in the industry appears to be promising through the forecast period. The capability to fuel competitive capabilities is one of the chief causes powering their efforts in this period. Moreover, the contenders are handling the competitive environment by driving the market growth factors to their advantage.

North America Dental Consumables Market Players are

• Institut Straumann AG
• Henry Schein Inc
• Patterson Dental Supply Inc.
• Dentsply Sirona
• Kerr Corporation
• Danaher Corporation
• GC orthodontics
• Planmeca Oy
• American Orthodontics

Industry Segments

The north america dental consumables market outlook is segmented on the basis of type and region. The type segment of the market comprises of dental prosthetics, dental restorative material, dental implants and dental regenerative material among others. The region-based segmentation of the dental consumable industry consists of geographical areas such as Europe, Latin America, North America, Middle East, Asia Pacific and Africa.

Detailed Regional Analysis

The regional analysis of the industry for dental consumables globally comprises of regions such as the Middle East and Africa, Europe, North America, Latin America and the Asia Pacific. The Americas region controls the main market portion and will carry on its role in guiding the market for the duration of the given forecast period due to the high acceptance of novel technologies and increased healthcare expenditures within the region. With the demand for dental consumables growing, due to the developments in dental treatments, shifting demographic trends, and a combination of other factors, the market is expanding at a good pace. Since some of the nations with better medical and healthcare facilities such as Brazil, US, and Canada. The European region is the second significant market due to the presence of well-developed economies and a sound healthcare structure. The rising skills of the oral healthcare domain across altered nations such as the Greece, U.K., Spain, and Italy among others have upgraded the possibility for development of the European region for dental consumables.

Intensification of focus on vendors from emerging markets, such as the Asia Pacific region is expected to improve the pace of market expansion. Additionally, growing demand for refining aesthetic appearance and developing awareness about dental consumables is estimated to positively add to the market development. In addition, the rise in the dental tourism for this region is expected to fuel the market expansion during the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Orthopedic Devices Market Share accelerating a CAGR during the forecast period 2023-2032

 

Market Overview

The global orthopedic devices market share is expected to reach a strong 6.50% CAGR over the forecast period from 2023 to 2032, according to the latest research report from Market Research Future (MRFR).

The global orthopedic devices market is mainly driven by the rising demand for technological upgradation in orthopedic devices, the rising prevalence of conditions requiring the use of orthopedic devices, such as osteoporosis, and the increasing growth prospects for the market in developing countries. Approximately 10 million U.S. citizens have osteoporosis, according to the National Osteoporosis Foundation, along with 44 million more with low bone density, which leaves them at a greater risk of osteoporosis and other bone disorders. Rising awareness about the disease and the effectiveness of orthopedic devices in correcting the problems caused by the disease is likely to be a major driver for the global orthopedic devices market over the forecast period.

Competitive Analysis:

Global Orthopedic Devices Market players include

ü  DePuy

ü  Synthes Companies,

ü  Medtronic,

ü  Smith & Nephew plc,

ü  Zimmer Inc.,

ü  Stryker Corporation,

ü  NuVasive Inc., and

ü  Globus Medical Inc.

Industry Updates and Opportunities:

Strong technological advancement is also likely to further the cause of the global orthopedic devices market over the forecast period. Technological advancement in the global orthopedic devices market mainly focuses on making the devices lighter and more easily wearable, apart from bringing about innovations that help manufacture the devices at a cheaper price. 3D printing is likely to become more popular in the global orthopedic devices market over the forecast period, as it allows for precise manufacturing at relatively cheap costs.

Segmentation:

The global orthopedic devices market outlook is segmented on the basis of type, application, end use, and region.

By type, the global orthopedic devices market insights is segmented into spinal devices, bone repair, joint replacement, trauma fixation, consumables and disposables, and others.

By application, the global orthopedic devices market is segmented into spine, knee, foot and ankle, hip, trauma and extremities, and others.

By end use, the global orthopedic devices market is segmented into hospitals, ambulatory surgery centers, and medical research centers. Hospitals are likely to remain the leading revenue generator in the global orthopedic devices market over the forecast period.

Regional Analysis:

North America holds the largest market share in the global orthopedic device market, accounting for 39.6% of the market in 2016. The growing prevalence of osteoporosis and other bone conditions in North America has been a major driver for the orthopedic devices market in the region. The strong presence of the technological framework required to adopt 3D printing on a large scale is also likely to be a major driver for the orthopedic devices market in North America over the forecast period. 3D printing has been pioneered in North America and many major 3D printing manufacturers are located in the region. This is likely to further the cause of the orthopedic devices market in North America over the forecast period.

Europe is also a major regional market for orthopedic devices and is expected to experience strong growth over the forecast period due to the growing number of osteoporosis cases in the region. The Europe market for orthopedic devices is expected to reach a valuation of USD 19,467.6 million by 2023.

Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the rising demand for advanced orthopedic devices to correct spinal and other bone-related conditions. The Asia Pacific market for orthopedic devices is expected to exhibit a strong 6.2% CAGR over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America